Last $33.60 USD
Change Today -0.32 / -0.94%
Volume 503.6K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

thoratec corp (THOR) Snapshot

Open
$33.79
Previous Close
$33.92
Day High
$34.35
Day Low
$33.51
52 Week High
10/31/13 - $43.58
52 Week Low
06/5/13 - $29.91
Market Cap
1.9B
Average Volume 10 Days
595.2K
EPS TTM
$1.34
Shares Outstanding
56.9M
EX-Date
--
P/E TM
25.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for THORATEC CORP (THOR)

thoratec corp (THOR) Related Businessweek News

No Related Businessweek News Found

thoratec corp (THOR) Details

Thoratec Corporation develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. The company’s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure; and PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. In addition, the company provides Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising home discharge and post-cardiotomy myocardial recovery. It sells its products through direct sales force and distributors in the United States and internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.

951 Employees
Last Reported Date: 02/18/14
Founded in 1976

thoratec corp (THOR) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $570.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $302.3K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $338.3K
Compensation as of Fiscal Year 2013.

thoratec corp (THOR) Key Developments

Thoratec Corp. Proposes Amendment to its Restated Articles of Association

Thoratec Corp. proposed the amendment to the restated articles of association concerning limitation of director liability and indemnification of agents in the annual general meeting to be held on May 21, 2014.

Willie Briscoe and Powers Taylor Announce Federal Class Action Lawsuit against Thoratec Corp. and Several Officers and Directors

Willie Briscoe and Powers Taylor announced that a federal class action lawsuit has been filed against Thoratec Corp. and several officers and directors for acts taken during the period of April 29, 2010 to December 27, 2013. Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Thoratec. In the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges that defendants' misrepresented and/or failed to disclose that Thoratec's HeartMate II Left Ventricular Assist Device had significant risk of pump thrombosis, resulting in numerous fatalities. Due to the foregoing, Thoratec's statements were materially false and misleading at all relevant times.

Daniel M. Mulvena to Retire from the Board of Thoratec Corporation

On March 13, 2014, Daniel M. Mulvena informed the Board of Directors of Thoratec Corporation, that he has decided to retire from the Board after seventeen years of service and accordingly he will not stand for re-election to the Board. Mr. Mulvena will continue to serve on the Board and as a member of the Compensation Committee of the Board until the Company’s 2014 Annual Meeting of Shareholders.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THOR:US $33.60 USD -0.32

THOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ArthroCare Corp $48.61 USD +0.11
Cyberonics Inc $62.02 USD +0.77
HeartWare International Inc $84.98 USD -0.90
NuVasive Inc $33.83 USD +0.40
Wright Medical Group Inc $28.42 USD +0.03
View Industry Companies
 

Industry Analysis

THOR

Industry Average

Valuation THOR Industry Range
Price/Earnings 27.0x
Price/Sales 3.8x
Price/Book 2.9x
Price/Cash Flow 26.3x
TEV/Sales 3.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THORATEC CORP, please visit www.thoratec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.